98 related articles for article (PubMed ID: 24694179)
1. Cisplatin binding to proteins: molecular structure of the ribonuclease a adduct.
Messori L; Merlino A
Inorg Chem; 2014 Apr; 53(8):3929-31. PubMed ID: 24694179
[TBL] [Abstract][Full Text] [Related]
2. Platinated oligomers of bovine pancreatic ribonuclease: Structure and stability.
Picone D; Donnarumma F; Ferraro G; Russo Krauss I; Fagagnini A; Gotte G; Merlino A
J Inorg Biochem; 2015 May; 146():37-43. PubMed ID: 25756333
[TBL] [Abstract][Full Text] [Related]
3. Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts.
Messori L; Marzo T; Merlino A
J Inorg Biochem; 2015 Dec; 153():136-142. PubMed ID: 26239545
[TBL] [Abstract][Full Text] [Related]
4. Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compound.
Messori L; Scaletti F; Massai L; Cinellu MA; Russo Krauss I; di Martino G; Vergara A; Paduano L; Merlino A
Metallomics; 2014 Feb; 6(2):233-6. PubMed ID: 24287583
[TBL] [Abstract][Full Text] [Related]
5. Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins.
Marzo T; Navas F; Cirri D; Merlino A; Ferraro G; Messori L; Quiroga AG
J Inorg Biochem; 2018 Apr; 181():11-17. PubMed ID: 29353085
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
[TBL] [Abstract][Full Text] [Related]
7. The ultrahigh resolution crystal structure of ribonuclease A containing an isoaspartyl residue: hydration and sterochemical analysis.
Esposito L; Vitagliano L; Sica F; Sorrentino G; Zagari A; Mazzarella L
J Mol Biol; 2000 Mar; 297(3):713-32. PubMed ID: 10731423
[TBL] [Abstract][Full Text] [Related]
8. Minimization of cavity size ensures protein stability and folding: structures of Phe46-replaced bovine pancreatic RNase A.
Kadonosono T; Chatani E; Hayashi R; Moriyama H; Ueki T
Biochemistry; 2003 Sep; 42(36):10651-8. PubMed ID: 12962489
[TBL] [Abstract][Full Text] [Related]
9. Structure of bovine pancreatic ribonuclease complexed with uridine 5'-monophosphate at 1.60 A resolution.
Larson SB; Day JS; Nguyen C; Cudney R; McPherson A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Feb; 66(Pt 2):113-20. PubMed ID: 20124705
[TBL] [Abstract][Full Text] [Related]
10. Peculiar features in the crystal structure of the adduct formed between cis-PtI2(NH3)2 and hen egg white lysozyme.
Messori L; Marzo T; Gabbiani C; Valdes AA; Quiroga AG; Merlino A
Inorg Chem; 2013 Dec; 52(24):13827-9. PubMed ID: 24256441
[TBL] [Abstract][Full Text] [Related]
11. Mapping the stability clusters in bovine pancreatic ribonuclease A.
Vilà R; Benito A; Ribó M; Vilanova M
Biopolymers; 2009 Dec; 91(12):1038-47. PubMed ID: 19373927
[TBL] [Abstract][Full Text] [Related]
12. Picoplatin binding to proteins: X-ray structures and mass spectrometry data on the adducts with lysozyme and ribonuclease A.
Ferraro G; Lyčková T; Massai L; Štarha P; Messori L; Merlino A
Dalton Trans; 2024 May; 53(20):8535-8540. PubMed ID: 38727007
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the dimerization process of a domain-swapped dimeric variant of human pancreatic ribonuclease.
Rodríguez M; Benito A; Ribó M; Vilanova M
FEBS J; 2006 Mar; 273(6):1166-76. PubMed ID: 16519682
[TBL] [Abstract][Full Text] [Related]
14. Interaction of cisplatin drug with RNase A.
Neault JF; Novetta-Delen A; Tajmir-Riahi HA
J Biomol Struct Dyn; 1999 Aug; 17(1):101-9. PubMed ID: 10496425
[TBL] [Abstract][Full Text] [Related]
15. Ionic interactions in crystalline bovine pancreatic ribonuclease A.
Fedorov AA; Joseph-McCarthy D; Fedorov E; Sirakova D; Graf I; Almo SC
Biochemistry; 1996 Dec; 35(50):15962-79. PubMed ID: 8973167
[TBL] [Abstract][Full Text] [Related]
16. A domain-swapped RNase A dimer with implications for amyloid formation.
Liu Y; Gotte G; Libonati M; Eisenberg D
Nat Struct Biol; 2001 Mar; 8(3):211-4. PubMed ID: 11224563
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
Kobe B; Deisenhofer J
J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
[TBL] [Abstract][Full Text] [Related]
18. Multiple solvent crystal structures of ribonuclease A: an assessment of the method.
Dechene M; Wink G; Smith M; Swartz P; Mattos C
Proteins; 2009 Sep; 76(4):861-81. PubMed ID: 19291738
[TBL] [Abstract][Full Text] [Related]
19. Toward an antitumor form of bovine pancreatic ribonuclease: the crystal structure of three noncovalent dimeric mutants.
Merlino A; Russo Krauss I; Perillo M; Mattia CA; Ercole C; Picone D; Vergara A; Sica F
Biopolymers; 2009 Dec; 91(12):1029-37. PubMed ID: 19280639
[TBL] [Abstract][Full Text] [Related]
20. It takes two to flirt with a dimeric RNase.
D'Alessio G
Biopolymers; 2009 Dec; 91(12):989-94. PubMed ID: 19156888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
